Besides, CDKN2B gene expression level in different AML subtypes didn’t reveal any significant correlation between expression level and methylation in different subtypes (M1: P=0.3, M2: P=0.5, M5: P=0.4, others: P=0.2). This evidence concerns the gene CDKN2B and acute myeloid leukemia.